Abstract

This study correlated conventional ultrasonography (US) signs with the magnetic resonance imaging (MRI) proton density fat fraction (PDFF) to evaluate the diagnostic performance of US signs (alone or combined) to predict presence and degree of hepatic steatosis (HS). Overall, 182 subjects met the study inclusion criteria between February 2014 and October 2016. Four US signs were evaluated independently by two radiologists. MRI PDFF was defined as the average of 24 non-overlapping regions of interest (ROIs) within eight liver segments obtained by drawing three ROIs within each segment. The latter acted as the reference standard to evaluate diagnostic accuracy of the US signs and their combinations. Diagnostic performance of US for HS was assessed using receiver operating characteristic (ROC) curve analyses. There was a strongly positive correlation between some combinations of US signs and PDFF (σ = 0.780, p < 0.001). The sensitivity, specificity, PPV, and NPV were 96.6%, 74.8%, 64.8%, and 97.9%, respectively, determined using abnormal hepatorenal echoes to detect grade 1 or higher HS (area under the ROC curve = 0.875). The sensitivity and NPV for detecting HS with US were good and US may be considered a suitable screening tool for exclusion of HS.

Highlights

  • Non-alcoholic fatty liver (NAFLD) is a leading cause of chronic liver disease in most developed countries

  • magnetic resonance imaging (MRI) proton density fat fraction (PDFF) is used a biomarker of hepatic steatosis (HS), the feasibility of using MRI PDFF in research and clinical settings is limited by the high cost and limited availability

  • 31 (17.0%), 12 (6.6%), and 16 (8.8%) were classified as having grade 1, 2, and 3 steatosis according to the MRI PDFF

Read more

Summary

Introduction

Non-alcoholic fatty liver (NAFLD) is a leading cause of chronic liver disease in most developed countries. MRI PDFF of the liver has been shown to have high diagnostic accuracy with histological steatosis grade[8,9,10] and has been recognized as the reference standard in diagnostic radiology[11,12]. Determination of MRI PDFF has been developed in various commercial software products [IDEAL IQ (GE), mDixon Quant (Philips), and Multiecho VIBE Dixon (Siemens)]. These have been used instead of liver biopsy in randomized controlled clinical studies[13,14] and usage is expected to increase in the future. MRI PDFF is used a biomarker of HS, the feasibility of using MRI PDFF in research and clinical settings is limited by the high cost and limited availability. The purpose of our study was to correlate conventional US signs to MRI PDFF and to evaluate the diagnostic accuracy of each US sign, and their combinations to predict the presence and degree of HS

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call